Skip to main content
    V

    VivoSim Labs, Inc. (VIVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.12
    -0.00 (-2.68%)

    Market Cap: $2.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    VivoSim Labs, Inc. (VIVS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    VivoSim Labs reported revenue of $131.00K for the fiscal year ended Mar 31, 2026, down 9.0% from the year before. That year, net income was -$13.84M with a net margin of -10567.2%, operating cash flow was -$10.83M and free cash flow was -$10.83M. The quarter ended Sep 30, 2026 had revenue of $51.00K and net income of -$475.00K.

    Revenue and Margins

    Over the 9 years to Mar 2026, revenue fell from $4.23M, a compound annual decline of 32.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Mar 2026$131.00K-9.0%100.0%-8768.7%-10567.2%
    Mar 2025$144.00K+32.1%96.5%-8761.1%-1727.8%
    Mar 2024$109.00K-70.5%100.0%-13840.4%-13459.6%
    Mar 2023$370.00K-75.3%100.0%-4792.2%-4664.6%
    Mar 2022$1.50MN/A100.0%-765.3%-763.2%
    Mar 2021$0-100.0%N/AN/AN/A
    Mar 2020$2.20M-29.0%85.1%-977.9%-852.0%
    Mar 2019$3.09M-32.8%84.4%-882.4%-861.7%
    Mar 2018$4.60M+8.8%77.6%-766.3%-756.1%
    Mar 2017$4.23MN/A77.4%-911.9%-908.9%
    Annual, fiscal years ended Mar 2017 to Mar 2026

    Income Statement

    In the fiscal year ended Mar 2026, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue$131.00K$144.00K$109.00K$370.00K$1.50M$0$2.20M$3.09M$4.60M$4.23M
    Cost of revenue$0$5.00K$0$0$0$0$328.00K$482.00K$1.03M$956.00K
    Gross profit$131.00K$139.00K$109.00K$370.00K$1.50M$0$1.87M$2.61M$3.57M$3.27M
    Research and development$4.19M$5.03M$5.50M$8.88M$3.32M$1.10M$5.28M$14.75M$17.96M$19.55M
    Operating income-$11.49M-$12.62M-$15.09M-$17.73M-$11.48M-$16.83M-$21.48M-$27.27M-$35.27M-$38.58M
    Net income-$13.84M-$2.49M-$14.67M-$17.26M-$11.45M-$16.83M-$18.71M-$26.64M-$34.80M-$38.45M
    EBITDAN/A-$2.35M-$14.40M-$17.41M-$11.31M-$16.80M-$20.22M-$26.36M-$34.01M-$37.47M
    Fiscal years ended Mar 2017 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$51.00K$18.00K$26.00K$28.00K$37.00K$51.00K$26.00K$30.00K$39.00K$29.00K$5.00K$0
    Gross profit-$5.00K$18.00K$26.00K$28.00K$37.00K$51.00K$26.00K$29.00K$37.00K$29.00K$5.00K$0
    Operating income-$3.32M-$2.76M-$2.75M-$2.63M-$2.92M-$3.15M-$2.75M-$2.61M-$3.39M-$3.10M-$3.68M-$4.12M
    Net income-$475.00K-$1.34M-$2.69M-$2.54M-$2.84M$6.85M-$2.69M-$2.55M-$3.34M-$3.04M-$3.60M-$3.99M
    Last 12 quarters

    Balance Sheet

    As of Mar 2026, cash and equivalents of $5.02M were 67.9% of total assets of $7.39M, against total liabilities of $8.48M.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Total assets$7.39M$14.65M$6.35M$20.31M$33.30M$39.92M$28.44M$40.62M$49.83M$69.18M
    Current assets$6.63M$12.13M$3.94M$17.05M$29.53M$38.40M$28.32M$38.57M$46.76M$65.09M
    Cash and equivalents$5.02M$11.31M$2.90M$15.30M$28.68M$37.36M$27.36M$36.48M$43.73M$62.75M
    Total liabilities$8.48M$4.16M$2.75M$4.98M$3.09M$721.00K$1.81M$4.33M$5.24M$6.82M
    Short-term debtN/A$521.00K$506.00K$492.00K$479.00KN/AN/AN/AN/AN/A
    Shareholder equity-$1.10M$10.49M$3.60M$15.33M$30.21M$39.20M$26.63M$36.30M$44.59M$62.36M
    Fiscal years ended Mar 2017 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$9.92M$3.85M$7.39M$6.96M$9.69M$11.98M$14.65M$6.96M$9.69M$9.47M$6.35M$8.88M
    Total liabilities$2.68M$6.19M$8.48M$2.52M$2.62M$2.44M$4.16M$2.52M$2.62M$2.81M$2.75M$2.70M
    Cash and equivalents$8.56M$1.67M$5.02M$4.29M$6.68M$9.05M$11.31M$4.29M$6.68M$6.19M$2.90M$5.29M
    Shareholder equity$7.24M-$2.35M-$1.10M$4.44M$7.07M$9.54M$10.49M$4.44M$7.07M$6.66M$3.60M$6.18M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Mar 2026.

    Annual

    Line itemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating cash flow-$10.83M-$9.46M-$14.65M-$12.41M-$8.45M-$13.32M-$14.88M-$20.38M-$28.86M-$29.18M
    Capital expenditures$0$13.00K$42.00K$396.00K$409.00K$405.00K$0$79.00K$226.00K$1.35M
    Free cash flow-$10.83M-$9.47M-$14.70M-$12.80M-$8.86M-$13.73M-$14.88M-$20.45M-$29.08M-$30.54M
    Share repurchases$0$0$0$0$0$1.00K$0N/AN/AN/A
    Investing cash flow$94.00K$9.03M$816.00K-$966.00K-$409.00K-$393.00K$747.00K-$76.00K-$292.00K-$1.39M
    Financing cash flow$4.45M$8.85M$1.44M$0$205.00K$23.84M$4.93M$13.15M$10.11M$31.25M
    Fiscal years ended Mar 2017 to Mar 2026

    Quarterly

    Line itemSep 2026Jun 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$2.48M-$3.21M-$2.96M-$2.38M-$3.94M-$2.04M-$2.96M-$2.64M-$2.98M-$2.67M-$3.52M-$3.15M
    Capital expenditures$62.00K$23.00K$13.00K$0$0$0$13.00K$13.00K$0$0$0$27.00K
    Free cash flow-$2.54M-$3.24M-$2.98M-$2.38M-$3.94M-$2.04M-$2.98M-$2.65M-$2.98M-$2.67M-$3.52M-$3.18M
    Last 12 quarters

    Frequently Asked Questions About VIVS

    What is VivoSim Labs' annual revenue?

    VivoSim Labs reported revenue of $131.00K for the fiscal year ended Mar 31, 2026.

    How fast is VivoSim Labs' revenue growing?

    Revenue was down 9.0% for the fiscal year ended Mar 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -29.3%.

    Is VivoSim Labs profitable?

    No. VivoSim Labs reported net income of -$13.84M for the fiscal year ended Mar 31, 2026, with a net margin of -10567.2%.

    How much free cash flow does VIVS generate?

    For the fiscal year ended Mar 31, 2026, operating cash flow of -$10.83M minus capital expenditures of $0 produced free cash flow of -$10.83M.

    How much debt does VivoSim Labs have?

    The balance sheet dated Mar 31, 2026 reported cash and equivalents of $5.02M.